« Previous
Next »
Urologic Oncology: Seminars and Original Investigations
Volume 30, Issue 1
, Pages 16-20
, January 2012
GREB1 tissue expression is associated with organ-confined prostate cancer
References
- Cancer statistics, 2009 . CA Cancer J Clin . 2009;59:1–25
- . Clinical evidence for and implications of the multistep development of prostate cancer . J Urol . 1990;143:742–746
- A prospective comparison of prostate cancer at autopsy and as a clinical event: The Hawaii Japanese experience . Cancer Epidemiol Biomarkers Prev . 1992;1:189–193
- Cancer control with radical prostatectomy alone in 1,000 consecutive patients . J Urol . 2002;167:528–534
- The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer . J Urol . 1993;150:110–114
- Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer (A multi-institutional update) . JAMA . 1997;277:1445–1451
- Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma . Cancer . 1997;79:528–537
- Gene expression correlates of clinical prostate cancer behavior . Cancer Cell . 2002;1:203–209
-
Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens
.
Scand J Urol Nephrol Suppl
. 2005;216:34–63
- . Predicting prostate cancer behavior using transcript profiles . J Urol . 2004;172:S28–S32
- GREB 1 is a critical regulator of hormone dependent breast cancer growth . Breast Cancer Res Treat . 2005;92:141–149
- GREB1 is a novel androgen-regulated gene required for prostate cancer growth . Prostate . 2006;66:886–894
- TMEFF2 is an androgen-regulated gene exhibiting antiproliferative effects in prostate cancer cells . Oncogene . 2002;21:4739–4746
- . Gammopathy associated with advanced prostate carcinoma . Urol Res . 1995;23:185–188
- Trihydrophobin 1 is a new negative regulator of A-RAF kinase . J Biol Chem . 2004;279:10167–10175
☆ This study was supported by FAPESP (Fundação de Amparo à Pesquisa do Estado de Sao Paulo) under the protocol number 2006/56492-5.
PII: S1078-1439(09)00295-6
doi: 10.1016/j.urolonc.2009.09.014
© 2012 Elsevier Inc. All rights reserved.
« Previous
Next »
Urologic Oncology: Seminars and Original Investigations
Volume 30, Issue 1
, Pages 16-20
, January 2012
